ZA918512B - Morphine prodrugs - Google Patents

Morphine prodrugs

Info

Publication number
ZA918512B
ZA918512B ZA918512A ZA918512A ZA918512B ZA 918512 B ZA918512 B ZA 918512B ZA 918512 A ZA918512 A ZA 918512A ZA 918512 A ZA918512 A ZA 918512A ZA 918512 B ZA918512 B ZA 918512B
Authority
ZA
South Africa
Prior art keywords
pct
morphine
date
sec
prodrugs
Prior art date
Application number
ZA918512A
Other languages
English (en)
Inventor
Hans Bundgaard
Bundgaard Hans
Lona Christrup
Christrup Lona
Joern Drustrup
Drustrup Joern
Ann Fullerton
Fullerton Ann
Martin Nicklasson
Nicklasson Martin
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Publication of ZA918512B publication Critical patent/ZA918512B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA918512A 1990-11-16 1991-10-25 Morphine prodrugs ZA918512B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003665A SE9003665D0 (sv) 1990-11-16 1990-11-16 Morphine prodrugs

Publications (1)

Publication Number Publication Date
ZA918512B true ZA918512B (en) 1992-08-26

Family

ID=20380936

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA918512A ZA918512B (en) 1990-11-16 1991-10-25 Morphine prodrugs

Country Status (18)

Country Link
US (1) US5908846A (de)
EP (1) EP0557385B1 (de)
JP (1) JP3493434B2 (de)
AT (1) ATE168560T1 (de)
AU (1) AU655612B2 (de)
CA (1) CA2095223C (de)
DE (1) DE69129861T2 (de)
DK (1) DK0557385T3 (de)
ES (1) ES2121793T3 (de)
FI (1) FI932212A7 (de)
IE (1) IE913682A1 (de)
IL (1) IL99905A (de)
NO (1) NO931766D0 (de)
NZ (1) NZ240349A (de)
PT (1) PT99513B (de)
SE (1) SE9003665D0 (de)
WO (1) WO1992008459A1 (de)
ZA (1) ZA918512B (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5607691A (en) * 1992-06-12 1997-03-04 Affymax Technologies N.V. Compositions and methods for enhanced drug delivery
DE4403709A1 (de) * 1994-02-07 1995-08-10 Lohmann Therapie Syst Lts Pharmazeutische Zusammensetzung zur systemischen transdermalen Verabreichung mit dem Wirkstoff Morphin-6-glucuronid
JPH07267862A (ja) * 1994-03-29 1995-10-17 Sekisui Chem Co Ltd 経皮吸収貼付剤
DE19508664C2 (de) * 1995-03-14 2001-08-23 Christian Mignat Verwendung von Morphin-3-estern, Morphin-3-ester als solche und Verfahren zu deren Herstellung
WO1996028451A1 (en) * 1995-03-14 1996-09-19 Euroceltique S.A. Morphine-3-esters
GB9519363D0 (en) 1995-09-22 1995-11-22 Euro Celtique Sa Pharmaceutical formulation
DE19602971A1 (de) * 1995-12-20 1997-07-31 Nycomed Arzneimittel Gmbh Neue 7,8-Dihydromorphinderivate, Verfahren zu deren Herstellung und deren Verwendung
DE19923551A1 (de) * 1999-05-21 2000-11-30 Lohmann Therapie Syst Lts Pharmazeutisches Präparat mit dem Wirkstoff Diamorphin und seine Verwendung in einem Verfahren zur Behandlung der Opiatsucht
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
AU764453B2 (en) 1999-10-29 2003-08-21 Euro-Celtique S.A. Controlled release hydrocodone formulations
US20020013331A1 (en) * 2000-06-26 2002-01-31 Williams Robert O. Methods and compositions for treating pain of the mucous membrane
MXPA03003895A (es) 2000-10-30 2003-07-28 Euro Celtique Sa Formulaciones de hidrocodona de liberacion controlada.
US6569449B1 (en) * 2000-11-13 2003-05-27 University Of Kentucky Research Foundation Transdermal delivery of opioid antagonist prodrugs
AUPR549901A0 (en) * 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
ATE444756T1 (de) * 2000-11-14 2009-10-15 Vital Health Sciences Pty Ltd Zusammensetzungen umfassend komplexe von tocopherolphosphatderivaten
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
KR20040014544A (ko) * 2001-06-05 2004-02-14 컨트롤 딜리버리 시스템즈 인코포레이티드 서방 진통제 화합물
WO2003011303A1 (en) * 2001-07-27 2003-02-13 Vital Health Sciences Pty Ltd Dermal therapy using phosphate derivatives of electron transfer agents
CA2466536C (en) * 2001-12-13 2012-02-07 Vital Health Sciences Pty Ltd Transdermal transport of compounds
AU2002950713A0 (en) * 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
DE60329515D1 (de) * 2002-10-25 2009-11-12 Euro Celtique Sa Analoga und prodrugs von buprenorphin
WO2004043396A2 (en) * 2002-11-09 2004-05-27 Nobex Corporation Modified carbamate-containing prodrugs and methods of synthesizing same
WO2004064831A1 (en) * 2003-01-17 2004-08-05 Vital Health Sciences Pty Ltd Compounds having anti-proliferative properties
AU2003901815A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
DK1638492T3 (da) * 2003-07-25 2008-05-13 Euro Celtique Sa Præoperativ behandling af postoperativ smerte
PL1711502T3 (pl) * 2004-02-06 2009-02-27 Euro Celtique Sa Sposoby wytwarzania 3-o-zabezpieczonych morfinonów i karboksylanów 3-o-zabezpieczonych dienoli morfinonu
HRP20090363T1 (hr) 2004-02-23 2009-08-31 Euro-Celtique S.A. Transdermalni injektor opioida rezistentan na zlouporabu
DK1720551T3 (da) 2004-03-03 2011-05-16 Vital Health Sciences Pty Ltd Alkaloidformuleringer
NZ565049A (en) 2005-06-17 2012-02-24 Vital Health Sciences Pty Ltd A carrier comprising one or more DI and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
US20090005348A1 (en) * 2005-12-23 2009-01-01 Vital Health Sciences Pty Ltd Compounds Having Cytokine Modulating Properties
CA2679316C (en) 2007-03-02 2016-11-29 Teika Pharmaceutical Co., Ltd. Morphine composition for transdermal absorption, morphine composition storing unit and transdermal absorption preparation using the same
US9511016B2 (en) * 2007-06-12 2016-12-06 Epicentrx, Inc. Topical composition for treating pain
US8354116B2 (en) * 2007-06-18 2013-01-15 Biochemics, Inc. Bifunctional synthetic molecules
US20090130048A1 (en) * 2007-11-19 2009-05-21 Oronsky Bryan Todd Topical Composition for Treating Pain
US8784872B2 (en) 2007-11-19 2014-07-22 Comgenrx, Inc. Formulation for decreasing tobacco, alcohol, drug or food consumption
WO2009158667A2 (en) * 2008-06-27 2009-12-30 Comgenrx, Inc. Povidone compositions for wound healing
EP2448408A4 (de) 2009-07-02 2015-06-03 Kempharm Inc Phenylethanolsäure-, phenylpropansäure- und phenylpropensäure-konjugate und prodrugs aus hydrocodon, herstellungsverfahren und verwendung
US10849981B2 (en) 2009-07-02 2020-12-01 KemPham, Inc. Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof
UA102916C2 (uk) * 2009-07-02 2013-08-27 Кемфарм, Інк. Композиція на основі кон'югату гідрокодону з бензойною кислотою, похідними бензойної кислоти або гетероарилкарбоновою кислотою, проліки, спосіб лікування від зловживань
ES2999020T3 (en) 2010-02-05 2025-02-24 Phosphagenics Ltd Carrier comprising non-neutralised tocopheryl phosphate
EP2552486B1 (de) 2010-03-30 2020-08-12 Phosphagenics Limited Pflaster für transdermale verabreichung
JP5927506B2 (ja) 2010-04-13 2016-06-01 レルマダ セラピューティクス、インク． １−メチル−２’，６’−ピペコロキシリダイドの皮膚医薬組成物および使用方法
TWI520732B (zh) 2011-01-18 2016-02-11 輝瑞有限公司 固體分子分散液
WO2012122586A1 (en) 2011-03-15 2012-09-20 Phosphagenics Limited New composition
NZ731591A (en) 2014-11-25 2018-06-29 Kempharm Inc Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxycodone
CN114712308A (zh) 2015-12-09 2022-07-08 磷肌酸有限公司 药物制剂
EP3558903B1 (de) 2016-12-21 2024-07-03 Avecho Biotechnology Limited Verfahren zur phosphorylierung eines komplexen alkohols

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4673679A (en) * 1986-05-14 1987-06-16 E. I. Du Pont De Nemours And Company Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration
US4908389A (en) * 1986-08-27 1990-03-13 Warner-Lambert Company Penetration enhancement system
US4940586A (en) * 1987-02-26 1990-07-10 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US4879297A (en) * 1987-06-01 1989-11-07 Warner-Lambert Company Fatty acids and their small chain esters as penetration enhancers in aqueous systems
US4891377A (en) * 1988-12-02 1990-01-02 Board Of Regents Acting For And On Behalf Of University Of Michigan Transdermal delivery of the narcotic analgesics etorphine and analogs
ES2094809T3 (es) * 1990-03-30 1997-02-01 Yasunori Morimoto Composicion absorbible por via percutanea del clorhidrato de morfina.
US5069909A (en) * 1990-06-20 1991-12-03 Cygnus Therapeutic Systems Transdermal administration of buprenorphine

Also Published As

Publication number Publication date
NO931766L (no) 1993-05-14
WO1992008459A1 (en) 1992-05-29
ES2121793T3 (es) 1998-12-16
FI932212L (fi) 1993-05-14
CA2095223A1 (en) 1992-05-17
FI932212A0 (fi) 1993-05-14
DK0557385T3 (da) 1999-04-26
IE913682A1 (en) 1992-05-20
IL99905A0 (en) 1992-08-18
NZ240349A (en) 1993-07-27
DE69129861D1 (de) 1998-08-27
ATE168560T1 (de) 1998-08-15
AU8938191A (en) 1992-06-11
JP3493434B2 (ja) 2004-02-03
AU655612B2 (en) 1995-01-05
PT99513A (pt) 1992-09-30
PT99513B (pt) 1999-04-30
EP0557385B1 (de) 1998-07-22
DE69129861T2 (de) 1999-04-01
NO931766D0 (no) 1993-05-14
EP0557385A1 (de) 1993-09-01
SE9003665D0 (sv) 1990-11-16
CA2095223C (en) 2002-12-17
FI932212A7 (fi) 1993-05-14
JPH06502422A (ja) 1994-03-17
US5908846A (en) 1999-06-01
IL99905A (en) 1995-06-29

Similar Documents

Publication Publication Date Title
IL99905A0 (en) Morphine prodrugs
MY107158A (en) 3-arylcarbonyl; -1h-indoles useful as therapeutic agents.
GB2270075B (en) Substituted 2-phenyl-3-methoxypropenoate fungicides
SI0889886T1 (en) Novel phenanthridines substituted in the 6 position
MX9700886A (es) Nuevas oxazolidinonas sustituidas.
FI954963A0 (fi) Poly-1-n-alkeeniamiineja ja näitä sisältäviä poltto- ja voiteluainekoostumuksia
MY105761A (en) Dispensing devices powered by hydrogel
BG103740A (en) Phytostyrene composition for the prevention of the alzheimer's disease
MY114014A (en) Imidazole compounds, compositions and use
BG102259A (en) Compostions with controlled paroxetine release
MY106109A (en) 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions
GEP20032953B (en) Antitumor Agents
KR0166663B1 (en) Use of il-10 to prevent insulin-dependent diabetes mellitus
IL126235A0 (en) Compounds with growth hormone releasing properties
TW271397B (de)
PL345204A1 (en) Compounds with growth hormone releasing properties
IL109866A (en) Crystalline 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine(+)L-hydrogentartrate its preparation and pharmaceutical compositions containing it
CA2015197A1 (en) Phenolic amine depigmenting and antimelanoma agents
ES2013025A6 (es) Un metodo para preparar 24r-escimnol.
MX9701606A (es) Terapia de combinacion para evitar la perdida osea-progesterona y agonistas de estrogeno.
ES2097816T5 (es) Producto y su uso para el tratamiento de estados catabolicos que comprende ifg-1 autentico y cantidades hipocaloricas de nutrientes.
AU7719491A (en) Therapeutic compound
IL100765A0 (en) Vaccine composition against influenza,with synergic effects containing influenza virus core as an additive
GR3036205T3 (en) Use of phosphorus derivatives of alkaloids for treating endocrinopathies
MY108690A (en) Mildewproofing agent for timber